# Myocardial Blood Flow by PET and N-13 Ammonia During Regadenoson vs Adenosine Stress

> **NCT01370265** · NA · COMPLETED · sponsor: **Mayo Clinic** · enrollment: 12 (actual)

## Conditions studied

- Coronary Artery Disease

## Interventions

- **DRUG:** Regadenoson
- **DRUG:** Adenosine
- **DRUG:** N-13 ammonia

## Key facts

- **NCT ID:** NCT01370265
- **Lead sponsor:** Mayo Clinic
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2011-02
- **Primary completion:** 2012-02
- **Final completion:** 2012-06
- **Target enrollment:** 12 (ACTUAL)
- **Last updated:** 2013-09-05

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01370265

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01370265, "Myocardial Blood Flow by PET and N-13 Ammonia During Regadenoson vs Adenosine Stress". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT01370265. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*